Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children

Pediatric Infectious Disease Journal

Volumn 23, Issue 8, 2004, Pages 701-706

  Martínez Aguilar, Gerardo ^a,b   Avalos Mishaan, Ana ^c   Hulten, Kristina ^c   Hammerman, Wendy ^c   Mason Jr , Edward O ^c   Kaplan, Sheldon L ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Methicillin resistance; Musculoskeletal infections; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; METICILLIN; PENICILLIN G; VANCOMYCIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DRUG WITHDRAWAL; EPIDEMIOLOGICAL DATA; FEMALE; FEVER; GENETIC CODE; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MUSCULOSKELETAL DISEASE; OSTEOMYELITIS; PEDIATRICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYOMYOSITIS; RANK SUM TEST; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STRAIN DIFFERENCE; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DEMOGRAPHY; FEMALE; HUMANS; LENGTH OF STAY; MALE; METHICILLIN RESISTANCE; MUSCULOSKELETAL DISEASES; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VIRULENCE;

EID: 4043050071     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000133044.79130.2a     Document Type: Article

References (26)

1. Krogstad P. Osteomyelitis and septic arthritis. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL, eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia: Saunders; 2004:713-736.
2. Wong M, Isaacs D, Howman-Giles R, Uren R. Clinical and diagnostic features of osteomyelitis occurring in the first three months of life. Pediatr Infect Dis J. 1995;14:1047-1053.
3. Chambers HF. The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis. 2001;7:178-182.
4. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593-598.
5. Fergie JF, Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J. 2001;20:860-863.
6. Sattler CA, Mason EO Jr., Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002;21:910-915.
7. Salmenlinna S, Lyytikäinen O, Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis. 2002;8:602-606.
8. Gwynne-Jones DP, Stott NS. Community-acquired methicillin-resistant Staphylococcus aureus: a cause of musculoskeletal sepsis in children. J Pediatr Orthopaed. 1999;19:413-416.
9. Hill PC, Wong CG, Voss LM, et al. Prospective study of 125 cases of Staphylococcus aureus bacteremia in children in New Zealand. Pediatr Infect Dis J. 2001;20:868-873.
10. Frank AL, Marcinak JF, Mangat D, Schreckenberger PC. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J. 1999;18:993-1000.
11. Martinez-Aguilar G, Hammerman W, Mason EO Jr., Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003;7:593-598.
12. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin- resistant Staphylococcus aureus infection in France: Emergence of a single clone that produces Panton-Valentine-leukocidin. Clin Infect Dis. 2002;35:819-824.
13. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753-759.
14. Fey PD, Said-Salim B, Rupp ME, et al. Comparative molecular analysis of community-or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003;47:196-203.
15. Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:262-282.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests: approved standard. 8th ed. NCCLS document M2-A8. Wayne, PA: National Committee for Clinical Laboratory Standards; 2003.
17. th edition. NCCLS document M100-S13 (M7). Wayne, PA: National Committee for Clinical Laboratory Standards; 2003.
18. Leclercq R, Courvalin P. Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification. Antimicrob Agents Chemother. 1991;35:1267-1272.
19. Del Vecchio VG, Petroziello JM, Gress MJ, et al. Molecular genotyping of methicillin-resistant Staphylococcus aureus via fluorophore-enhanced repetitive-sequence PCR. J Clin Microbiol. 1995;33:2141-2144.
20. Cho S-H, Strickland I, Boguniewicz M, Leung DYM. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol. 2001;108:269-274.
21. Lina G, Piémont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-1132.
22. Peltola H, Unkila-Kallio L, Kallio MJ. Simplified treatment of acute staphylococcal osteomyelitis of childhood: the Finnish Study Group. Pediatrics. 1997;9:846-850.
23. Kaplan SL, Mason EO Jr., Feigin RD. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. South Med J. 1982;75:138-142.
24. Prevost G, Bouakham T, Piemont Y, Monteil H. Characterisation of a synergohymenotropic toxin produced by Staphylococcus intermedius. FEBS Lett. 1995;376:135-140.
25. Jupiter JB, Ehrlich MG, Novelline RA, Leeds HC, Keim D. The association of septic thrombophlebitis with subperiosteal abscesses in children. J. Pediatr. 1982;101:690-695.
26. Gorenstein A, Gross E, Houri S, Gewirts G, Katz S. The pivotal role of deep vein thrombophlebitis in the development of acute disseminated staphylococcal disease in children. Pediatrics 2000;106(6). URL:http:// www.pediatrics.org/cgi/content/full/106/6/e87.